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bstract
Polyethylene microspheres (microparticles) were prepared using a modified chemical route. The prepared powder samples were
haracterized using scanning electron microscopy, Fourier transform infrared spectroscopy and differential scanning calorimetry. The
canning electron microscopy images show that the concentration of polyglycolic acid decreased the agglomeration and increased
he degree of sphericity of the polyethylene microspheres. The results show that the polyethylene microparticles may be good
andidates as drug carriers for pulmonary drug delivery.
 2015 Taibah University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
http://creativecommons.org/licenses/by-nc-nd/4.0/).
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.  Introduction
Various methods are available for the administration
f drugs, including intravenous, intradermal, subcu-
aneous, oral (e.g., inhalation), transdermal (topical),
ransmucosal, and rectal administrations. The oral and
ransdermal methods are the simplest routes of drug
dministration. However, for the oral method, there
s a risk of drug decomposition by the digestive∗ Corresponding author. Tel.: +91 8275309162.
E-mail address: ssdeshmukh.2009@rediffmail.com
S.S. Deshmukh).
eer review under responsibility of Taibah University.
ttp://dx.doi.org/10.1016/j.jtusci.2015.06.007
658-3655 © 2015 Taibah University. Production and hosting by Elsevier B.V
http://creativecommons.org/licenses/by-nc-nd/4.0/).organs, whereas when transdermal methods are used, the
adsorption efficiency of a drug is generally low. The
injection method results in a high adsorption efficiency,
which is an early effect of the pharmacological actions
of the injected drug, and there is no risk of drug decom-
position by the digestive organs. However, because the
method can result in pain at the injection site, it is
difficult to administer injection-based drugs to patients
with belonephobia. In recent years, there has been a
growing interest in the pulmonary route of drug admin-
istration because pulmonary administration is simple,
shows the effects of the pharmacological action of the
drug early on, and has no risk of drug decomposi-
tion [1–3]. Pulmonary administration is a method that
works via the lungs. Among the several types of drug. This is an open access article under the CC BY-NC-ND license
carriers, including liposomes [4,5], micelles [6–9], and
gels [10–12], polymeric “particles” are suitable for pul-
monary drug administration [13]. In this method, the
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Table 1
Constituents used for the preparation of the polyethylene
microparticles.
Xylene 40 ml
Polyethylene 4 bags (wt. of one bag = 1.601 g)486 S.S. Deshmukh, V.S. Sangawar / Journal of
drug-incorporated particle is aspirated into the lung
and decomposed via transcytosis, and then the drug
is absorbed into the body. The drug-absorption effi-
ciency is high because the lungs have relatively large
surface areas, thin alveolar epithelial cells, and signifi-
cant blood capillaries. Some noteworthy properties are
required for a drug carrier to be used for pulmonary
administration. First, it is important to use biocompatible
or biodegradable materials, such as polyethylene glycol
(PEG) or poly (lactide-co-glycolide) (PLGA). Second,
it is important to control the diameter and density of
the particles because large particles (over 10 m) can be
trapped in the pharynx or the bronchi [14–16]. In con-
trast, small particles (less than 1 m) are emitted during
breathing. An appropriate diameter of particles for pul-
monary drug delivery is reported to be 1–5 m [17]. For
the preparation of such particles, solvent evaporation-
based methods are used in which the resulting particles
have a high density. Specifically, when porous parti-
cles are prepared, particles having a low density are
obtained using this method [18]. In contrast, particles
having a low density are generally obtained with spray
dry-based preparation methods. Third, it is important to
modify the surface of the particles. Particles that have
functional molecules (e.g., functional polymers) on the
surface can bind to the tissue surface and, consequently,
tend to be absorbed into the tissue. Generally, chemical
conjugation of polymers to particles is expensive and
time consuming because the conjugation chemistry must
be optimized for each polymer-particle combination.
Additionally, commercially available biocompatible and
biodegradable polymers, such as PLGA and polylactide
(PLA), are known to be materials in which the surface
modification of the resulting particles is difficult. This
is because PLGA and PLA contain almost no reactive
functional groups. Thus, there is a need for micropar-
ticle preparation methods that prepare suitable carriers
for pulmonary drug delivery. Bunn [19] reported a novel
technique to prepare nanoparticles that are modified with
hydrophilic polymers on the surface of the particles via a
“block copolymer-assisted” emulsification/evaporation
process using the solvent evaporation method. They con-
cluded that the spray dry-based method is suitable for
the preparation of microparticles for pulmonary drug
delivery.
In the present study, we discuss the preparation of
polyethylene microparticles using a modified chemical
route for pulmonary drug delivery. The prepared pow-
der samples were characterized using scanning electron
microscopy (SEM), Fourier transform infrared spec-
troscopy (FT-IR) and differential scanning calorimetry
(DSC).Glycolic acid Varying concentrations (0.3, 3, 5, and 7 g)
2.  Experimental
The constituents that were used for the preparation of
the polyethylene microparticles are provided in Table 1.
Small pieces of polyethylene were placed in a beaker
containing 40 ml of xylene with a small amount of
glycolic acid. Then, the solution was stirred using a mag-
netic stirrer at 100 ◦C until the powder form of PLGA
was obtained. Sample powders with different concentra-
tions of glycolic acid (0.3, 3, 5, 7 g) were prepared using
this technique. After the synthesis, the powder samples
were characterized at room temperature. Fig. 1 shows
the adopted synthesis method for the preparation of the
polyethylene microparticles.
The morphology and spherical shape of the pre-
pared particles were observed using scanning electron
microscopy (SEM, JSM-6700F). The Fourier trans-
form infrared spectra between 450 and 1500 cm−1 were
obtained at room temperature with a Perkin Elmer
Spectrum 400 FTIR spectrometer. Differential scanning
calorimetry was performed using a DSC-Q20 V24.11
(heating rate: 50 ◦C/min; gas flow: air).
3.  Results  and  discussion
3.1.  Surface  morphology  of  the  polyethylene
particles
The SEM micrographs of the prepared materials at
different concentrations of glycolic acid are shown in
Fig. 2. The polyethylene microparticle sizes increased at
a concentration of glycolic acid from 3 m to 9 m. The
microparticles agglomerated when a lower concentration
of acid was used. Additionally, when lower concen-
trations of glycolic acid were used, the polyethylene
microparticles were not completely spherical. However,
when 5 or 7 g were used, a high degree of sphericity
and agglomeration of a few of the microparticles was
observed.
3.2.  FT-IR  analysisAlthough polyethylene may be considered at first
approximation to be an infinite chain of CH2 groups,
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he chains are found in two different configurations. In
he crystalline regions, the chain is found in a planar
ig-zag configuration, as determined from X-ray diffrac-
ion studies [20]. In the amorphous regions, which can
onstitute up to half of the specimen [21], the chain
ig. 2. SEM images of the polyethylene microparticles prepared using differe
 g.ion of the polyethylene microparticles.
configuration is essentially random and is restricted
only by the conservation of the bond angles and dis-
tances [22]. The random configuration of the amorphous
regions becomes partially oriented when the sample is
stretched [21]. Thus, the usual spectrum of polyethylene
nt concentrations of glycolic acid: (A) 0.3 g, (B) 3 g, (C) 5 g, and (D)
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Fig. 3. FT-IR spectra after 3 g of glycolic acid were added to the polyethylene microparticles.
d were added to the polyethylene microparticles.
Table 2
“As received” DSC characterization of the polyethylene samples.
Polyethylene
sample containing
X grams of
glycolic acid
Melting onset
temperature (◦C)
Melting peak
temperature (◦C)
X = 0.3 g 139.5 161.74
X = 3 g 152.5 162.67Fig. 4. DSC curve after 3 g of glycolic aci
represents a superposition of the spectra of two different
types of chain configurations. Fig. 3 displays the FT-IR
spectra of the polyethylene (using 3 g of glycolic acid)
microparticles in wavenumbers.
3.3.  DSC  analysis
Fig. 4 displays the DSC curve for the sample con-
taining 3 g of glycolic acid. For this measurement, a
sample weighing approximately 5 mg was heated at
10 ◦C/min. The figure shows the melting endotherm for
one of the polyethylene samples during the initial “as
received” heating. The results for the studied samples are
X = 5 g 154 163.60
X = 7 g 157.5 165.45
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.  Conclusions
Polyethylene microspheres were successfully pre-
ared using a modified chemical synthesis technique.
he scanning electron microscopy images show that for
 lower concentration of polyglycolic acid, the poly-
thylene microspheres agglomerate with a lower degree
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esults show that polyethylene microparticles may be
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